Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.51

-0.45

-0.38

-0.32

Details

Expected EPS

-0.332751

Actual EPS

-0.32

Surprise EPS

0.01

Surprise Percent

+3.83%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.32 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.